Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00352469 · ClinicalTrials.gov registry record · Phase 4
Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety
A Phase 4 study, sponsored by Creighton University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00352469 is a Phase 4 study that has completed, run by Creighton University. The registered enrollment target is 20 participants.
The verdict
NCT00352469, a Phase 4 study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Alcohol use disorders (AUDs) are a major problem facing our society. Their treatment is complex, and involves multiple behavioral and pharmacotherapy interventions. There are 3 approved medications for AUDs, but their efficacy for AUDs that co-exist with anxiety disorders is unknown. This study explores the effects of the medication, sustained-release quetiapine fumarate (Seroquel SR) for the treatment of alcohol dependence and co-morbid anxiety. Primary outcome measure is the amount of alcohol used. Secondary outcome measures include craving for alcohol, length of sobriety from drinking and level of anxiety with Seroquel SR.
Interventions
- DRUG Seroquel XR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-02 |
| Est. Completion | 2008-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00352469
The ClinicalTrials.gov registry entry for NCT00352469 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Seroquel XR is the first listed.
NCT00352469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00352469 about?
NCT00352469 is a clinical study titled "Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety". Alcohol use disorders (AUDs) are a major problem facing our society. Their treatment is complex, and involves multiple behavioral and pharmacotherapy interventions. There are 3 approved medications for AUDs, but their efficacy for AUDs that co-exist with anxiety disorders is unknown. This study expl...
What is the current status of trial NCT00352469?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2006-02. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00352469?
The interventions under investigation include: Seroquel XR (DRUG).
Who is sponsoring clinical trial NCT00352469?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.